Bridgeway Capital Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-95,143
| Closed | -$660K | – | 1305 |
|
|
2024
Q3 | $660K | Hold |
95,143
| – | – | 0.01% | 791 |
|
|
2024
Q2 | $466K | Hold |
95,143
| – | – | 0.01% | 874 |
|
|
2024
Q1 | $552K | Hold |
95,143
| – | – | 0.01% | 897 |
|
|
2023
Q4 | $623K | Hold |
95,143
| – | – | 0.01% | 888 |
|
|
2023
Q3 | $459K | Hold |
95,143
| – | – | 0.01% | 904 |
|
|
2023
Q2 | $485K | Hold |
95,143
| – | – | 0.01% | 912 |
|
|
2023
Q1 | $523K | Buy |
95,143
+5,700
| +6% | +$31.4K | 0.01% | 875 |
|
|
2022
Q4 | $411K | Buy |
89,443
+20,500
| +30% | +$94.1K | 0.01% | 930 |
|
|
2022
Q3 | $430K | Hold |
68,943
| – | – | 0.01% | 927 |
|
|
2022
Q2 | $307K | Buy |
+68,943
| New | +$307K | 0.01% | 991 |
|
|
2019
Q4 | – | Sell |
-8,138
| Closed | -$90K | – | 1394 |
|
|
2019
Q3 | $90K | Hold |
8,138
| – | – | ﹤0.01% | 1251 |
|
|
2019
Q2 | $228K | Hold |
8,138
| – | – | ﹤0.01% | 1157 |
|
|
2019
Q1 | $217K | Buy |
8,138
+4,700
| +137% | +$125K | ﹤0.01% | 1212 |
|
|
2018
Q4 | $98K | Hold |
3,438
| – | – | ﹤0.01% | 1307 |
|
|
2018
Q3 | $264K | Buy |
+3,438
| New | +$264K | ﹤0.01% | 1277 |
|